Detalus Advisors, LLC Amgen Inc Transaction History

Detalus Advisors, LLC

$288 Million
Q4 2024

A detailed history of Detalus Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Detalus Advisors, LLC holds 1,151 shares of AMGN stock, worth $356,487. This represents 0.1% of its overall portfolio holdings.

Number of Shares

1,151

Previous 1,148 0.26%

Holding current value

$356,487

Previous $369,000 18.97%

% of portfolio

0.1%

Previous 0.13%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$258.78 - $328.31 $776 - $984	3 Added 0.26%	1,151 $299,000
Q2 2024 Jul 26, 2024	BUY	$262.75 - $319.31 $16,290 - $19,797	62 Added 5.71%	1,148 $358,000
Q4 2023 Jan 24, 2024	BUY	$255.7 - $288.46 $9,716 - $10,961	38 Added 3.63%	1,086 $312,000
Q3 2023 Oct 26, 2023	SELL	$218.65 - $271.46 $37,170 - $46,148	-170 Reduced 13.96%	1,048 $281,000
Q2 2023 Jul 28, 2023	BUY	$214.27 - $253.37 $27,426 - $32,431	128 Added 11.74%	1,218 $270,000
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $17,864 - $22,698	-78 Reduced 6.68%	1,090 $286,000
Q3 2022 Nov 04, 2022	SELL	$224.46 - $253.15 $32,097 - $36,200	-143 Reduced 10.91%	1,168 $263,000
Q2 2022 Jul 27, 2022	SELL	$230.71 - $256.74 $92,284 - $102,696	-400 Reduced 23.38%	1,311 $319,000
Q1 2022 Apr 25, 2022	SELL	$219.27 - $242.57 $21,927 - $24,257	-100 Reduced 5.52%	1,711 $414,000
Q4 2021 Jan 18, 2022	SELL	$198.88 - $227.6 $121,117 - $138,608	-609 Reduced 25.17%	1,811 $407,000
Q3 2021 Oct 20, 2021	BUY	$212.27 - $248.7 $30,142 - $35,315	142 Added 6.23%	2,420 $515,000
Q2 2021 Jul 14, 2021	SELL	$233.58 - $259.14 $9,343 - $10,365	-40 Reduced 1.73%	2,278 $555,000
Q1 2021 Apr 15, 2021	BUY	$221.91 - $258.6 $197,056 - $229,636	888 Added 62.1%	2,318 $577,000
Q4 2020 Jan 19, 2021	BUY	$216.38 - $257.67 $432 - $515	2 Added 0.14%	1,430 $329,000
Q3 2020 Nov 18, 2020	BUY	$234.65 - $260.95 $35,197 - $39,142	150 Added 11.74%	1,428 $363,000
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $1,822 - $2,417	10 Added 0.79%	1,278 $259,000
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $239,918 - $308,377	1,268 New	1,268 $306,000

Others Institutions Holding AMGN

# of Institutions

3,166

Shares Held

418M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Detalus Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Detalus Advisors, LLC with notifications on news.

Account

Detalus Advisors, LLC Amgen Inc Transaction History